Title : Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.

Pub. Date : 2002 Dec 20

PMID : 12447997






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pre-treatment of the PC-3 cells with LPA decreases the dose of EGF required to elicit maximal activation of EGFR. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
2 Furthermore, treatment with LPA alone induces the rapid (maximal signal within 2 min) tyrosine phosphorylation of EGFR, and subsequent (maximal signal after 5 min) activation of ERK, suggesting that EGFR activation precedes ERK phosphorylation and may constitute a required component for signal relay from the LPA receptor to ERK. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
3 Furthermore, treatment with LPA alone induces the rapid (maximal signal within 2 min) tyrosine phosphorylation of EGFR, and subsequent (maximal signal after 5 min) activation of ERK, suggesting that EGFR activation precedes ERK phosphorylation and may constitute a required component for signal relay from the LPA receptor to ERK. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
4 Accordingly, we show that inhibition of EGFR kinase activity attenuates the LPA-regulated ERK activation. lysophosphatidic acid epidermal growth factor receptor Homo sapiens
5 In addition, we find that the LPA-regulated tyrosine phosphorylation of EGFR and activation of ERK are attenuated by batimastat, a generic inhibitor of matrix metalloproteinases (MMP). lysophosphatidic acid epidermal growth factor receptor Homo sapiens
6 However, unlike the situation in fibroblasts, we find that the LPA-induced transactivation of EGFR in PC-3 cells is not mediated by shedding of heparin-binding EGF. lysophosphatidic acid epidermal growth factor receptor Homo sapiens